Exports For Foreign Trials Would Need Ethics Review Under Rep. Lantos Bill
Executive Summary
A bill by Rep. Tom Lantos (D-Ca.) would require drug manufacturers exporting test product for overseas clinical trials to prove that the foreign protocol would pass U.S. standards for human subject protection